BRAF and cancer: This example comparing BRAF and NRAS in melanoma illustrates a general point that, in addition to the variation among genes in the per-nucleotide mutation rate, there are at least two other sources of variation that affect what we might call the “oncogenic mutation rate,” meaning the rate of occurrence of mutations that actually contribute to cancer growth.